Based on the Schrodinger Inc stock forecast from 5 analysts, the average analyst target price for Schrodinger Inc is USD 31.50 over the next 12 months. Schrodinger Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Schrodinger Inc is Bearish, which is based on 1 positive signals and 6 negative signals. At the last closing, Schrodinger Inc’s stock price was USD 26.19. Schrodinger Inc’s stock price has changed by -1.32% over the past week, +20.14% over the past month and +7.82% over the last year.
No recent analyst target price found for Schrodinger Inc
No recent average analyst rating found for Schrodinger Inc
Company Overview Schrodinger Inc
Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. It has a research collaboration and license agreement with Novartis Pharma AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York. Read Less
Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment sel...Read More
Frequently Asked Questions About Schrodinger Inc (SDGR) Stock
Based on ratings from 5 analysts Schrodinger Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 5 buy, sell and 1 hold ratings.
Unfortunately we do not have enough data on SDGR's stock to indicate if its a good dividend stock.
Based on targets from 5 analysts, the average taret price for SDGR is USD 31.50 over the next 12 months. The maximum analyst target price is USD 45 while the minimum anlayst target price is USD 27.
SDGR stock's Price/Earning ratio is 44.98.
Our analysis grades SDGR stock's Price / Earning ratio at D+. This means that SDGR stock's Price/Earning ratio is above 32% of the stocks in the Health Information Services sector in the NSD exchange.
Based on this SDGR may be fairly valued for its sector
The last closing price of SDGR's stock was USD 26.19.
The most recent market capitalization for SDGR is USD 1.79B.
Based on targets from 5 analysts, the average taret price for SDGR is projected at USD 31.50 over the next 12 months.
This means that SDGR's stock price may go up by +20.27% over the next 12 months.
We can't find any ETFs which contains Schrodinger Inc's stock.
As per our most recent records Schrodinger Inc has 891 Employees.
Schrodinger Inc's registered address is 1540 Broadway, New York, NY, United States, 10036.
You can get more information about it from Schrodinger Inc's website at https://www.schrodinger.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Frequently Asked Questions About Schrodinger Inc (SDGR) Stock
Based on ratings from 5 analysts Schrodinger Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 5 buy, sell and 1 hold ratings.
Unfortunately we do not have enough data on SDGR's stock to indicate if its a good dividend stock.
Based on targets from 5 analysts, the average taret price for SDGR is USD 31.50 over the next 12 months. The maximum analyst target price is USD 45 while the minimum anlayst target price is USD 27.
SDGR stock's Price/Earning ratio is 44.98.
Our analysis grades SDGR stock's Price / Earning ratio at D+. This means that SDGR stock's Price/Earning ratio is above 32% of the stocks in the Health Information Services sector in the NSD exchange.
Based on this SDGR may be fairly valued for its sector
The last closing price of SDGR's stock was USD 26.19.
The most recent market capitalization for SDGR is USD 1.79B.
Based on targets from 5 analysts, the average taret price for SDGR is projected at USD 31.50 over the next 12 months.
This means that SDGR's stock price may go up by +20.27% over the next 12 months.
We can't find any ETFs which contains Schrodinger Inc's stock.
As per our most recent records Schrodinger Inc has 891 Employees.
Schrodinger Inc's registered address is 1540 Broadway, New York, NY, United States, 10036.
You can get more information about it from Schrodinger Inc's website at https://www.schrodinger.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for SDGR !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
